CS
SWTX

Credit Suisse’s SpringWorks Therapeutics SWTX Stock Holding History

Credit Suisse’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.91M Buy
59,198
+22,179
+60% +$1.03M ﹤0.01% 1617
2023
Q4 		$1.35M Buy
37,019
+3,589
+11% +$93.7K ﹤0.01% 2145
2023
Q3 		$773K Sell
33,430
-12,188
-27% -$333K ﹤0.01% 2449
2023
Q2 		$1.2M Buy
45,618
+13,379
+41% +$352K ﹤0.01% 2266
2023
Q1 		$830K Buy
32,239
+8,703
+37% +$254K ﹤0.01% 2446
2022
Q4 		$612K Sell
23,536
-2,392
-9% -$58.9K ﹤0.01% 2659
2022
Q3 		$741K Buy
25,928
+6,418
+33% +$184K ﹤0.01% 2541
2022
Q2 		$480K Buy
19,510
+566
+3% +$20.7K ﹤0.01% 2874
2022
Q1 		$1.07M Buy
18,944
+1,597
+9% +$91.4K ﹤0.01% 2503
2021
Q4 		$1.08M Buy
17,347
+2,538
+17% +$168K ﹤0.01% 3260
2021
Q3 		$939K Buy
14,809
+2,367
+19% +$182K ﹤0.01% 3395
2021
Q2 		$1.02M Sell
12,442
-1,047
-8% -$79.5K ﹤0.01% 3365
2021
Q1 		$993K Sell
13,489
-22,264
-62% -$1.74M ﹤0.01% 3328
2020
Q4 		$2.59M Buy
35,753
+10,681
+43% +$688K ﹤0.01% 2626
2020
Q3 		$1.2M Buy
25,072
+14,879
+146% +$634K ﹤0.01% 2800
2020
Q2 		$428K Buy
+10,193
New +$363K ﹤0.01% 3411
2019
Q4 		– Sell
-27,319
Closed -$592K – 4320
2019
Q3 		$592K Buy
+27,319
New +$646K ﹤0.01% 3346

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse's SWTX Position: Q1 2024 in Review

Credit Suisse increased its SpringWorks Therapeutics (SWTX) stake by 60% in Q1 2024, buying an estimated $1.03M and bringing the position to 59,198 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Credit Suisse first reported a position in SWTX in Q3 2019 and has held it in 17 quarters since. 217 funds tracked by Wall St. Rank hold SWTX as of Q1 2024.

  • Credit Suisse held 59,198 shares of SpringWorks Therapeutics worth $2.91M as of Q1 2024.
  • Credit Suisse bought 22,179 SpringWorks Therapeutics shares in Q1 2024, an estimated $1.03M.
  • SpringWorks Therapeutics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1617 holding.
  • Credit Suisse first reported a position in SpringWorks Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • 217 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.